Fatty Liver Disease
Pioglitazone reduces liver fat content and augments glucose uptake in diabetics
Published in Hepatitis Weekly, July 21st, 2003
"The effect of pioglitazone on splanchnic glucose uptake (SGU), endogenous glucose production (EGP), and hepatic fat content was studied in 14 type 2 diabetic patients (age 50±2 years, body mass index (BMI) 29.4±1.1 kg/m2, HbA(1c) 7.8±0.4%).," scientists writing in the journal Diabetes reported.
"Hepatic fat content (magnetic resonance spectroscopy) and SGU (oral glucose load-insulin clamp technique) were quantitated before and after pioglitazone (45 mg/day) therapy for 16 weeks. Subjects received a 7 hour (h) euglycemic insulin...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2003-07-21)
More Articles from Hepatitis Weekly
- Chronic Hepatitis C
Markov models suggest the natural history of HCV infection can be predicted - Chronic Hepatitis C
Moderate amounts of alcohol exacerbate liver disease through oxidative injury - Liver Transplantation
MELD scores don't interpret outcomes for living donor liver graft patients - Chronic Hepatitis C
An NS3 serine protease inhibitor disrupts subgenomic HCV RNA replication - Hepatitis B Virus Therapy
Short interfering RNA knocks out hepatitis B virus replication - Hepatitis C Virus Therapy
Interferon is suitable for chronic hepatitis C with autoimmune phenomenon - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
